Journal of Market Access and health Policy is the official Journal of MAS

Most recent:

21 Jul 2016:

Challenges in striving to simultaneously achieve multiple resource allocation goals: the pan-Canadian Oncology Drug Review (pCODR) example 

Heather McDonald, Cathy Charles, Laurie Elit, Amiram Gafni

20 Jul 2016:

Demonstrating the value of medicines: evolution of value equation and stakeholder perception of uncertainties

Siva Narayanan

28 Jun 2016:

Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles

Edward Gibson, Najida Begum, Federico Martinón-Torres, Marco Aurélio Safadi, Alfred Sackeyfio, Judith Hackett, Sankarasubramanian Rajaram

23 Jun 2016:

Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole

Craig Bennison, Stephanie Stephens, Benedicte Lescrauwaet, Ben van Hout, Timothy L. Jackson

20 Jun 2016:

Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations

Katia Thokagevistk, Aurélie Millier, Leslie Lenert, Shamil Sadikhov, Santiago Moreno, Mondher Toumi
 
10 May 2016:
Feasibility and attractiveness of indication value-based pricing in key EU countries
 
Mathias Flume, Marc Bardou, Stefano Capri, Oriol Sola-Morales, David Cunningham, Lars-Ake Levin, Nicolas Touchot
 
25 Apr 2016:
Advanced therapy medicinal products: current and future perspectives
 
Eve Hanna, Cécile Rémuzat, Pascal Auquier, Mondher Toumi
 
7 Apr 2016:
The value of innovation under value-based pricing Santiago G, Moreno, Joshua A. Ray
 
15 Mar 2016:
Drug Pricing Reform in China: analysis of piloted approaches and potential impact of the reform
 
Yixi Chen, Shanlian Hu, Peng Dong, Åsa Kornfeld, Patrycja Jaros, Jing Yan, Fangfang Ma, Mondher Toumi
 
21 Dec 2015:
Pharmaceutical Market Access: current state of affairs and key challenges – results of the Market Access Launch Excellence Inventory (MALEI)
 
Marcus A. Koch

Most viewed: 

12 Aug 2015:
The Economic Value of Vaccination: Why Prevention is Wealth
 
Special Issue
 
10 Sep 2015:
Overview of external reference pricing systems in Europe
 
Cécile Rémuzat, Duccio Urbinati, Olfa Mzoughi, Emna El Hammi, Wael Belgaied, Mondher Toumi
 
 
1 Dec 2014:
Pharmaceutical market access in emerging markets: concepts, components, and future
 
Anuj Kumar, Karthaveerya Juluru, Phani Kishore Thimmaraju, Jayachandra Reddy, Anand Patil
 
21 Dec 2015:
Pharmaceutical Market Access: current state of affairs and key challenges – results of the Market Access Launch Excellence Inventory (MALEI)
 
Marcus A. Koch
 
12 Mar 2015:
A comparison of HAS & NICE guidelines for the economic evaluation of health technologies in the context of their respective national health care systems and cultural environments
 
Marc Massetti, Samuel Aballéa, Yann Videau, Cécile Rémuzat, Julie Roïz, Mondher Toumi
 
15 Mar 2016:
Drug Pricing Reform in China: analysis of piloted approaches and potential impact of the reform
 
Yixi Chen, Shanlian Hu, Peng Dong, Åsa Kornfeld, Patrycja Jaros, Jing Yan, Fangfang Ma, Mondher Toumi
 
28 Jun 2016:
Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles
 
Edward Gibson, Najida Begum, Federico Martinón-Torres, Marco Aurélio Safadi, Alfred Sackeyfio, Judith Hackett, Sankarasubramanian Rajaram
 
18 Nov 2015:
Market access pathways for cell therapies in France
 
Cécile Rémuzat, Mondher Toumi, Jesper Jørgensen, Panos Kefalas
 
23 Jun 2016:
Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
 
Craig Bennison, Stephanie Stephens, Benedicte Lescrauwaet, Ben van Hout, Timothy L. Jackson
 
7 Apr 2016:
The value of innovation under value-based pricing
 
Santiago G, Moreno, Joshua A. Ray